Internal Medicine Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense de Madrid, Madrid, Spain.
Department of Public Health & Maternal and Child Health, Faculty of Medicine, Universidad Complutense de Madrid, 28040, Madrid, Spain.
Cardiovasc Diabetol. 2024 Aug 24;23(1):313. doi: 10.1186/s12933-024-02403-y.
We used the Spanish national hospital discharge data from 2016 to 2022 to analyze procedures and hospital outcomes among patients aged ≥ 18 years admitted for ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) according to diabetes mellitus (DM) status (non-diabetic, type 1-DM or type 2-DM).
We built logistic regression models for STEMI/NSTEMI stratified by DM status to identify variables associated with in-hospital mortality (IHM). We analyzed the effect of DM on IHM.
Spanish hospitals reported 201,950 STEMIs (72.7% non-diabetic, 0.5% type 1-DM, and 26.8% type 2-DM; 26.3% female) and 167,285 NSTEMIs (61.6% non-diabetic, 0.6% type 1-DM, and 37.8% type 2-DM; 30.9% female). In STEMI, the frequency of percutaneous coronary intervention (PCI) increased among non-diabetic people (60.4% vs. 68.6%; p < 0.001) and people with type 2-DM (53.6% vs. 66.1%; p < 0.001). In NSTEMI, the frequency of PCI increased among non-diabetic people (43.7% vs. 45.7%; p < 0.001) and people with type 2-DM (39.1% vs. 42.8%; p < 0.001). In NSTEMI, the frequency of coronary artery by-pass grafting (CABG) increased among non-diabetic people (2.8% vs. 3.5%; p < 0.001) and people with type 2-DM (3.7% vs. 5.0%; p < 0.001). In the entire population, lower IHM was associated with undergoing PCI (odds ratio [OR] [95% confidence interval] = 0.34 [0.32-0.35] in STEMI; 0.24 [0.23-0.26] in NSTEMI) or CABG (0.33 [0.27-0.40] in STEMI; 0.45 [0.38-0.53] in NSTEMI). IHM decreased over time in STEMI (OR = 0.86 [0.80-0.93]). Type 2-DM was associated with higher IHM in STEMI (OR = 1.06 [1.01-1.11]).
PCI and CABG were associated with lower IHM in people admitted for STEMI/NSTEMI. Type 2-DM was associated with IHM in STEMI.
我们使用了西班牙 2016 年至 2022 年的全国医院出院数据,分析了年龄≥18 岁因 ST 段抬高型心肌梗死(STEMI)和非 ST 段抬高型心肌梗死(NSTEMI)入院的患者中根据糖尿病(DM)状态(非糖尿病、1 型 DM 或 2 型 DM)进行的手术和医院结局。
我们为 STEMI/NSTEMI 构建了按 DM 状态分层的逻辑回归模型,以确定与院内死亡率(IHM)相关的变量。我们分析了 DM 对 IHM 的影响。
西班牙医院报告了 201950 例 STEMI(72.7%非糖尿病,0.5% 1 型 DM,26.8% 2 型 DM;26.3%女性)和 167285 例 NSTEMI(61.6%非糖尿病,0.6% 1 型 DM,37.8% 2 型 DM;30.9%女性)。在 STEMI 中,非糖尿病患者接受经皮冠状动脉介入治疗(PCI)的频率增加(60.4% vs. 68.6%;p<0.001)和 2 型 DM 患者(53.6% vs. 66.1%;p<0.001)。在 NSTEMI 中,非糖尿病患者接受 PCI 的频率增加(43.7% vs. 45.7%;p<0.001)和 2 型 DM 患者(39.1% vs. 42.8%;p<0.001)。在 NSTEMI 中,非糖尿病患者接受冠状动脉旁路移植术(CABG)的频率增加(2.8% vs. 3.5%;p<0.001)和 2 型 DM 患者(3.7% vs. 5.0%;p<0.001)。在整个人群中,较低的 IHM 与接受 PCI(STEMI 的比值比[OR] [95%置信区间]为 0.34 [0.32-0.35];NSTEMI 为 0.24 [0.23-0.26])或 CABG(STEMI 的比值比[OR]为 0.33 [0.27-0.40];NSTEMI 的比值比[OR]为 0.45 [0.38-0.53])相关。STEMI 中 IHM 随时间降低(OR=0.86 [0.80-0.93])。2 型 DM 与 STEMI 中的较高 IHM 相关(OR=1.06 [1.01-1.11])。
STEMI/NSTEMI 入院患者接受 PCI 和 CABG 与较低的 IHM 相关。2 型 DM 与 STEMI 中的 IHM 相关。